APA način citiranja

Isono, T., Kagiyama, N., Shibata, S., Nakajima, H., Matsui, Y., Takano, K., . . . Takayanagi, N. (2021). A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer. Thorac Cancer.

Čikaški stil citiranja

Isono, Taisuke, et al. "A Retrospective Analysis of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy for Advanced or Recurrent Non‐small Cell Lung Cancer." Thorac Cancer 2021.

MLA način citiranja

Isono, Taisuke, et al. "A Retrospective Analysis of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy for Advanced or Recurrent Non‐small Cell Lung Cancer." Thorac Cancer 2021.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.